DB18284InvestigationalProtein Based Therapies
CT-001: Overview.
- Also known as
- Human recombinant factor VIIa variant (P10Q, K32E, T106N, V253N), desialylated
- Code names
- CT-001
Resolves to
Compound
What you can answer from here — as of October 01, 2025
Which companies are running trials of CT-001, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account